EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Adaptive clinical trials in surgery: A scoping review of methodological and reporting quality

Phillip Staibano iD, Emily Oulousian, Tyler McKechnie iD, Alex Thabane, Samuel Luo, Michael K Gupta, Han Zhang, Jesse D Pasternak, Michael Au, Sameer Parpia iD, J E M Ted Young, Mohit Bhandari

PLOS ONE · 28.05.2024 · 19 (5) · e0299494

DOI: 10.1371/journal.pone.0299494 ↗

Kurz gefasst

Scoping Review in der Zeitschrift PLOS ONE, online erschienen am 28.05.2024. Verfasst von Phillip Staibano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Adaptive surgical trials are scarce, but adopting these methods may help elevate the quality of surgical research when large-scale RCTs are impractical.

Objective

Randomized-controlled trials (RCTs) are the gold standard for evidence-based healthcare. Despite an increase in the number of RCTs, the number of surgical trials remains unchanged. Adaptive clinical trials can streamline trial design and time to trial reporting. The advantages identified for ACTs may help to improve the quality of future surgical trials. We present a scoping review of the methodological and reporting quality of adaptive surgical trials. Evidence review We performed a search of Ovid, Web of Science, and Cochrane Collaboration for all adaptive surgical RCTs performed from database inception to October 12, 2023. We included any published trials that had at least one surgical arm. All review and abstraction were performed in duplicate. Risk of bias (RoB) was assessed using the RoB 2.0 instrument and reporting quality was evaluated using CONSORT ACE 2020. All results were analyzed using descriptive methods.

Findings

Of the 1338 studies identified, six trials met inclusion criteria. Trials were performed in cardiothoracic, oral, orthopedic, and urological surgery. The most common type of adaptive trial was group sequential design with pre-specified interim analyses planned for efficacy, futility, and/or sample size re-estimation. Two trials did use statistical simulations. Our risk of bias evaluation identified a high risk of bias in 50% of included trials. Reporting quality was heterogeneous regarding trial design and outcome assessment and details in relation to randomization and blinding concealment. Conclusion and relevance Surgical trialists should consider implementing adaptive components to help improve patient recruitment and reduce trial duration. Reporting of future adaptive trials must adhere to existing CONSORT ACE 2020 guidelines. Future research is needed to optimize standardization of adaptive methods across medicine and surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicHumansResearch DesignAdaptive Clinical Trials as TopicSurgical Procedures, Operative

Autor:innen und Institutionen

  • Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
  • Department of Health Research Methodology, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • McGill University School of Medicine, McGill University, Montreal, Quebec, Canada.
  • Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
  • Michael G. DeGroote School of Medicine, Hamilton, Ontario, Canada.
  • Endocrine Surgery Section Head, Division of General Surgery, Department of Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Phillip Staibano, Tyler McKechnie, Sameer Parpia

Zitieren

APA

Staibano, P., Oulousian, E., McKechnie, T., Thabane, A., Luo, S., Gupta, M. K., Zhang, H., Pasternak, J. D., Au, M., Parpia, S., Young, J. E. M. T., & Bhandari, M. (2024). Adaptive clinical trials in surgery: A scoping review of methodological and reporting quality. PLOS ONE, 19(5), e0299494. https://doi.org/10.1371/journal.pone.0299494

Vancouver

Staibano P, Oulousian E, McKechnie T, Thabane A, Luo S, Gupta MK, et al. Adaptive clinical trials in surgery: A scoping review of methodological and reporting quality. PLOS ONE. 2024;19(5):e0299494. doi:10.1371/journal.pone.0299494

BibTeX
@article{Staibano2024,
  author = {Staibano, Phillip and Oulousian, Emily and McKechnie, Tyler and Thabane, Alex and Luo, Samuel and Gupta, Michael K and Zhang, Han and Pasternak, Jesse D and Au, Michael and Parpia, Sameer and Young, J E M Ted and Bhandari, Mohit},
  title = {Adaptive clinical trials in surgery: A scoping review of methodological and reporting quality},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {5},
  pages = {e0299494},
  doi = {10.1371/journal.pone.0299494}
}
Kostenlos starten →